These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Proceedings: Mode of action of beta-adrenergic receptor blocking drugs in hypertension. Oliver NW Scott Med J; 1974 Jan; 19(1):43-4. PubMed ID: 4150625 [No Abstract] [Full Text] [Related]
23. Beta-blockers and the kidney. Epstein M; Oster JR Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329 [No Abstract] [Full Text] [Related]
24. Beta blocking drugs and the treatment of hypertension. Hammond JJ; Kirkendall WM Tex Med; 1978 Jul; 74(7):43-8. PubMed ID: 27876 [No Abstract] [Full Text] [Related]
25. Beta-blockers and hypertension: carbon copies or a real choice. Whipps RG; Fisher ML; Plotnick GD Compr Ther; 1984 Sep; 10(9):12-8. PubMed ID: 6149036 [TBL] [Abstract][Full Text] [Related]
26. [Beta-adrenergic receptor blockers in clinical practice]. Czuriga I; Edes I Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106 [TBL] [Abstract][Full Text] [Related]
27. Spironolactone in the treatment of hypertension: a review. Brest AN Clin Ther; 1986; 8(5):568-85. PubMed ID: 2876776 [No Abstract] [Full Text] [Related]
28. [Propanolol in arterial hypertension. Beta-blockaders. Recent advances]. Arauco R; Alagón A Prensa Med Mex; 1979; 44(5-6):97-104. PubMed ID: 45356 [No Abstract] [Full Text] [Related]
30. [Beta-receptor blockers in hypertension: nonselective or selective]. Fennis JF; van 't Laar A Ned Tijdschr Geneeskd; 1978 Dec; 122(49):1924-5. PubMed ID: 31572 [No Abstract] [Full Text] [Related]
31. Beta-adrenergic blockade in hypertension. Hansson L; Werkö L Am Heart J; 1977 Mar; 93(3):394-402. PubMed ID: 14497 [No Abstract] [Full Text] [Related]
32. [Beta blockaders in the treatment of hypertension. Part 2. Antihypertensive effect: hypotheses on the mechanism of action and practical methods of treatment]. Andrejak M; Fournier A; Hardin JM; Lambrey G; de Frémont JF; Coevoet B Coeur Med Interne; 1978; 17(3):381-400. PubMed ID: 31260 [No Abstract] [Full Text] [Related]
33. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension. Man in't Veld AJ; Schalekamp MA Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800 [TBL] [Abstract][Full Text] [Related]
35. [The beta-blockers in hypertension]. Plouin PF; Degoulet P; Tugayé A; du Temple C Rev Prat; 1984 Apr; 34(19):941-50. PubMed ID: 6144161 [No Abstract] [Full Text] [Related]
36. "Tailored" application of beta-blockers in hypertension: a continuing dilemma. Birkenhäger WH; de Leeuw PW; Wester A; Kho TL; Vandongen R; Falke HE Neth J Med; 1977; 20(3):116-22. PubMed ID: 18688 [No Abstract] [Full Text] [Related]
37. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone. Helgeland A J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S474-6. PubMed ID: 6208414 [TBL] [Abstract][Full Text] [Related]
38. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics. Wallin JD; Shah SV Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524 [TBL] [Abstract][Full Text] [Related]
39. Beta-blockers in the treatment of hypertension: are there clinically relevant differences? Weir MR Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545 [TBL] [Abstract][Full Text] [Related]
40. [Evaluation of myocardial relaxation in the treatment of arterial hypertension: vasodilators and beta blockers]. Gimeno JV; Martín G; Cosín J Rev Esp Cardiol; 1985; 38(5):342-7. PubMed ID: 2867585 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]